[1] |
Taki Y, Watanabe S, Sato’o Y, et al. The association between onset of Staphylococcal non-menstrual toxic shock syndrome with inducibility of toxic shock syndrome toxin-1 production[J]. Front Microbiol,2022,13:765317.
|
[2] |
Finegold SM. Anaerobic infections in humans: an overview[J]. Anaerobe,1995,1(1):3-9.
|
[3] |
Angrup A, Sood A, Ray P, et al. Clinical anaerobic infections in an Indian tertiary care hospital: A two-year retrospective study[J]. Anaerobe,2022,73:102482.
|
[4] |
Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment[J]. Clin Infect Dis,2006,43(11):1436-1446.
|
[5] |
Zerrouki H, Rebiahi SA, Elhabiri Y, et al. Prevalence and antimicrobial resistance of PaeniClostridium sordellii in hospital settings[J]. Antibiotics,2021,11(1):38.
|
[6] |
Sirigi Reddy AR, Girinathan BP, Zapotocny R, et al. Identification and characterization of Clostridium sordellii toxin gene regulator[J]. J
|
[7] |
Vidor CJ, Hamiot A, Wisniewski J, et al. A highly specific holin-mediated mechanism facilitates the secretion of lethal toxin TcsL in PaeniClostridium sordellii[J]. Toxins,2022,14(2):124.
|
[8] |
Stothard P, Wishart DS. Circular genome visualization and exploration using CGView[J]. Bioinformatics,2005,21(4):537-539.
|
[9] |
Tian S, Liu Y, Wu H, et al. Genome-Wide CRISPR screen identifies semaphorin 6A and 6B as receptors for PaeniClostridium sordellii toxin TcsL[J]. Cell Host Microbe,2020,27(5):782-792. e7.
|
[10] |
Vidor C, Awad M, Lyras D. Antibiotic resistance, virulence factors and genetics of Clostridium sordellii[J]. Res Microbiol,2015,166(4):368-374.
|
[11] |
Jank T, Aktories K. Structure and mode of action of Clostridial glucosylating toxins: the ABCD model[J]. Trends Microbiol,2008,16(5):222-229.
|
[12] |
Awad MM, Singleton J, Lyras D. The sialidase NanS enhances non-TcsL mediated cytotoxicity of Clostridium sordellii[J]. Toxins,2016,8(189):1-15.
|
[13] |
Orrell KE, Melnyk RA. Large Clostridial toxins: mechanisms and roles in disease[J]. Microbiol Mol Biol Rev,2021,85(3):e0006421.
|
[14] |
中国医师协会急诊医师分会. 中国"脓毒症早期预防与阻断"急诊专家共识[J]. 中华危重病急救医学,2020,32(5):518-530.
|
[15] |
曹敬荣,王岩,谢威, 等. 质谱技术快速鉴定临床分离丝状真菌的应用[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(5):374-379.
|
[16] |
Vidor CJ, Bulach D, Awad M, et al. PaeniClostridium sordellii and Clostridioides difficile encode similar and clinically relevant tetracycline resistance loci in diverse genomic locations[J]. BMC Microbiol,2019,19(1):53-65.
|
[17] |
Sárvári KP, Schoblocher D. The antibiotic susceptibility pattern of gas gangrene-forming Clostridium spp. clinical isolates from South-Eastern Hungary[J]. Infect Dis (Lond),2020,52(3):196-201.
|
[18] |
Nakamura S, Yamakawa K, Nishida S. Antibacterial susceptibility of Clostridium sordellii strains[J]. Zentralbl Bakteriol Mikrobiol Hyg A,1986,261(3):345-349.
|
[19] |
Brazier JS, Levett PN, Stannard AJ. Antibiotic susceptibility of clinical isolates of Clostridia[J]. J Antimicrob Chemother,1985,15(2):181-185.
|
[20] |
Silva J, Henry R, Strickland M, et al. Rapidly fatal necrotizing soft tissue infection due to Clostridium sordellii in an injection drug user[J]. Am J Emerg Med,2021,44:480. e1-480. e3.
|
[21] |
王燕,张会英,吴俊, 等. 48例厌氧菌血流感染的临床特点及耐药性分析[J/CD]. 中华实验和临床感染病杂志(电子版),2017,11(6):573-577.
|
[22] |
Guzzetta M, Williamson A, Duong S. Clostridium sordellii as an uncommon cause of fatal toxic shock syndrome in a postpartum 33-year-old Asian woman, and the need for antepartum screening for this Clostridia species in the general female population[J]. Lab Med,2016,47(3):251-254.
|
[23] |
Ji HJ, Zhang Y. The role of pharmacist in scientific antimicrobial management strategy in the ICU[J]. Critical Care Medicine,2019,47(8):e718-e719.
|
[24] |
Couchman EC, Browne HP, Dunn M, et al. Clostridium sordellii genome analysis reveals plasmid localized toxin genes encoded within pathogenicity loci[J]. BMC Genomics,2015,16(1):392.
|
[25] |
Bonnecaze AK, Stephens SE, Miller PJ. Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcoma [J]. BMJ Case Rep,2016,2016(1):1-3.
|